Competitive advantages through pharmaceutical formulations

March 9, 2020 Competitive advantages through pharmaceutical formulations

Pharmind article about the Industry survey that predicts increasing investment in formulation development

The stability and competitive edge provided by drug formulations strongly impact drug costs and benefits in multiple ways. Direct costs are represented in the product invoice, but indirect costs are not apparent at first glance. These include regulatory issue clarification, product losses, and recalls. Optimum formulation offers significant competitive advantage, which is often underestimated during early development. This can offer competitors, that otherwise rank second or third in the market, access to larger market shares.

Undoubtedly, "Do it right the first time" should be the formulation motto of the future. Keeping this in mind, Rentschler Biopharma SE and LEUKOCARE AG entered a strategic alliance in 2017 to support both long-standing and new clients with world class formulation solutions. Hence, we enable the transformation of medical research into outstanding biopharmaceuticals, from concept to market.

You can find the pharmind article here (German only).

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication